Kodak’s share price is down 10 percent today after a massive rally over the past few days. The company’s now a key part of the Trump administration’s plan to bring drug manufacturing back to America. Emel Akan has the details.
Trump Administration’s Kodak deal
By Paul Greaney
Sign up for NTD Daily
What you need to know, summarized in one email.
Stay informed with accurate news you can trust.
Stay informed with accurate news you can trust.
Success! You are now subscribed.
By registering for the newsletter, you agree to the Privacy Policy.